The Fate of Plasma Exchange and Glucocorticoid Dosing in ANCA-Associated Vasculitis After PEXIVAS

Affiliations

¹ New York Nephrology Vasculitis and Glomerular Center, Albany, NY; Massachusetts General Hospital Vasculitis and Glomerulonephritis Center, Boston, MA; St. Peter's Health Partners, Albany, NY.
² Massachusetts General Hospital Vasculitis and Glomerulonephritis Center, Boston, MA. Electronic address: jlniles@mgh.harvard.edu.

Editorial

Frank B Cortazar et al. Am J Kidney Dis. 2020 Oct.

. 2020 Oct;76(4):595-597.

doi: 10.1053/j.ajkd.2020.03.010. Epub 2020 Apr 8.

¹ New York Nephrology Vasculitis and Glomerular Center, Albany, NY; Massachusetts General Hospital Vasculitis and Glomerulonephritis Center, Boston, MA; St. Peter's Health Partners, Albany, NY.
² Massachusetts General Hospital Vasculitis and Glomerulonephritis Center, Boston, MA. Electronic address: jlniles@mgh.harvard.edu.

No abstract available

Comment on

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
Walsh M, Merkel PA, Peh CA, Szpirt WM, Puéchal X, Fujimoto S, Hawley CM, Khalidi N, Floßmann O, Wald R, Girard LP, Levin A, Gregorini G, Harper L, Clark WF, Pagnoux C, Specks U, Smyth L, Tesar V, Ito-Ihara T, de Zoysa JR, Szczeklik W, Flores-Suárez LF, Carette S, Guillevin L, Pusey CD, Casian AL, Brezina B, Mazzetti A, McAlear CA, Broadhurst E, Reidlinger D, Mehta S, Ives N, Jayne DRW; PEXIVAS Investigators. Walsh M, et al. N Engl J Med. 2020 Feb 13;382(7):622-631. doi: 10.1056/NEJMoa1803537. N Engl J Med. 2020. PMID: 32053298 Free PMC article. Clinical Trial.